Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
- Citation:
- J Clin Oncol vol 26 (34) 5603-5609
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 416
- Children:
- None
- Pharmas:
- Grants:
- CA-37404, CA-35431, CA-35195, CA-114740, CA-35103, CA-25224, CA-60276, CA-108961, R01 CA127716, CA-35113, CA-63848, CA-37417, CA-35269, CA-35101, CA-35267, CA-63849
- Corr. Author:
- Authors:
- Paul D. Brown Sunil Krishnan Jann N. Sarkaria Wenting Wu Kurt A. Jaeckle Joon H. Uhm Francois J. Geoffroy Robert Arusell Gaspar Kitange Robert B. Jenkins John W. Kugler Roscoe F. Morton Kendrith M. Rowland Paul Mischel William H. Yong Bernd W. Scheithauer David Schiff Caterina Giannini Jan C. Buckner
- Networks:
- Study
- NCCTG-N0177
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Neurooncology